Liraglutide vs. Semaglutide: Daily or Weekly?

Liraglutide and semaglutide are different medicines, and the injection schedule is only part of the choice. Saxenda is a daily liraglutide injection; Wegovy injection is taken weekly. Their doses are not interchangeable. Before comparing a service's price, establish the actual product, prescribed regimen and quantity it supplies.^{1, 2}

For someone choosing between treatment services, our starting point is a prescription-specific comparison. Ask the clinician which option fits your history, then compare the cost and practical demands of that plan. A large average trial result cannot tell you whether a particular advertisement buys the treatment studied.

What the head-to-head trial found

STEP 8 randomized 338 adults with overweight or obesity, without diabetes. It compared weekly semaglutide targeting 2.4 mg with daily liraglutide targeting 3 mg, alongside diet and activity counseling. At 68 weeks, average weight change was −15.8% versus −6.4%: a 9.4 percentage-point difference favoring semaglutide.³

The active-treatment comparison was open-label. The escalation schedules and options for intolerance also differed. These results describe the tested regimens and population; they are not a promise for an individual, a diabetes population or a compounded product. They also do not test current Wegovy tablets or its newer 7.2 mg injection option.^{1, 2, 3}

If you are also considering tirzepatide, read our separate semaglutide-versus-tirzepatide comparison. Keep the specific trial, formulation and dose attached to every result you compare.

Daily versus weekly changes the routine

The Saxenda label specifies a daily injection, while Wegovy injection uses a weekly schedule. In an uninterrupted four-week period that means 28 daily administrations versus four weekly administrations. That arithmetic describes the routine, not the number of pens, vials or needles a particular pharmacy supplies.^{1, 2}

Think about the routine you can manage alongside work, travel and existing care. Ask who provides injection teaching and what to do if instructions are unclear. A service that advertises a daily treatment should explain the quantity and replacement schedule just as clearly as one selling a weekly treatment.

Do not apply one product's missed-dose instructions to the other. Ask the prescribing team for the instructions attached to your actual medicine. Our travel and refill checklist helps organize storage, documentation and supply questions without changing your prescribed schedule.

Similar stomach symptoms do not mean identical tolerability

In STEP 8, gastrointestinal adverse events were reported by 84.1% of the semaglutide group and 82.7% of the liraglutide group. Treatment discontinuation for any reason was 13.5% and 27.6%, respectively. The latter figures are not rates of stopping specifically because of side effects.³

Both approved labels contain important warnings and contraindications, including a boxed thyroid C-cell tumor warning. Your medical history and other medicines matter; frequency alone cannot establish that one is safer for you.^{1, 2} NIDDK recommends choosing weight-management medication with a health professional, considering benefits, side effects, health conditions, other medicines and cost.⁴

Ask what clinical contact is available when symptoms interfere with treatment. Coaching and administrative messaging answer different questions from a prescribing clinician. Our side-effects evidence guide explains why a common trial symptom and a warning needing medical attention should not be treated as the same finding.

Compare the actual products, not just molecule names

Saxenda and Wegovy are the branded products used as reference points here. Current Wegovy labeling includes both injection and tablet presentations, as well as more than one injection regimen. The STEP 8 result concerns its studied injection regimen, not every product carrying the semaglutide name.^{1, 2}

Compounded drugs are not FDA-approved; FDA does not review their safety, effectiveness or quality before marketing. An advertised compounded liraglutide or semaglutide preparation should not inherit an approved product's trial result or directions simply because a molecule name matches.⁵

Request the exact product and dispensing pharmacy, then discuss its rationale and instructions with the clinician and pharmacist. Our compounded-versus-brand guide separates those questions, and the pharmacy verification guide shows what to check about the actual dispenser.

A monthly headline needs a supply calculation

For each quote, obtain the medication quantity, prescribed use and usable supply period. Then itemize required membership, consultation, testing, supplies and delivery charges. Ask whether a higher prescribed dose changes the amount shipped, the next debit or both. Do not turn a bottle price into a monthly treatment budget without those answers.

Compare both plans over the same period. A four-week supply and a calendar-month charge need different calculations, and a prepaid annual equivalent does not describe the next card payment. Leave unresolved costs unpriced rather than substituting the cheapest advertised number. Our four-week-versus-monthly guide and six-month cost comparison walk through those purchasing differences.

A useful written quote makes the selected treatment and its financial commitment understandable together. Ask how cancellation affects unused medication payments and a separate membership. If the clinician changes the prescription, establish how that changes an already authorized purchase before agreeing to a longer commitment.

Agree on the follow-up decision before enrolling

Saxenda's adult labeling includes a response assessment 16 weeks after starting and a stopping criterion if less than 4% of baseline weight has been lost. That is a product-specific prescribing instruction, not a universal rule for every GLP-1 or a reason to change treatment yourself.¹

Ask your clinician when they will review response, symptoms and the longer-term plan. Include the cost of follow-up and any individually required tests in the service comparison; our lab-monitoring guide helps frame those questions. If an existing prescription is involved, use the provider-transfer checklist to organize records and continuity with both practices.

The strongest purchase decision combines an appropriate clinical plan with a clear bill and accessible follow-up. Neither the weekly schedule nor the cheapest daily-treatment headline establishes all three.